Borris LC - Search Results

1

Use of the low-molecular-weight heparin reviparin to prevent deep-vein thrombosis after leg injury requiring immobilization.

Lassen MR, Borris LC, Nakov RL. Lassen MR, et al. Among authors: borris lc. N Engl J Med. 2002 Sep 5;347(10):726-30. doi: 10.1056/NEJMoa011327. N Engl J Med. 2002. PMID: 12213943 Free article. Clinical Trial.

2

Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty.

Lassen MR, Ageno W, Borris LC, Lieberman JR, Rosencher N, Bandel TJ, Misselwitz F, Turpie AG; RECORD3 Investigators. Lassen MR, et al. Among authors: borris lc. N Engl J Med. 2008 Jun 26;358(26):2776-86. doi: 10.1056/NEJMoa076016. N Engl J Med. 2008. PMID: 18579812 Free article. Clinical Trial.

3

Association between plasma levels of tissue plasminogen activator and postoperative deep vein thrombosis--influence of prophylaxis with a low molecular weight heparin. The Venous Thrombosis Group.

Sørensen JV, Borris LC, Lassen MR, Christiansen HM, Schøtt P, Olsen AD, Neerstrand HS. Sørensen JV, et al. Among authors: borris lc. Thromb Res. 1990 Jul 1;59(1):131-8. doi: 10.1016/0049-3848(90)90278-k. Thromb Res. 1990. PMID: 2169077 Clinical Trial.

4

Perioperative thrombosis prophylaxis with low molecular weight heparins in elective hip surgery. Clinical and economic considerations.

Borris LC, Lassen MR, Jensen HP, Andersen BS, Poulsen KA. Borris LC, et al. Int J Clin Pharmacol Ther. 1994 May;32(5):262-8. Int J Clin Pharmacol Ther. 1994. PMID: 7921522

5

Venography in deep venous thrombosis: postoperative screening of patients in prophylaxis studies.

Borris LC, Lassen MR. Borris LC, et al. Haemostasis. 1993 Mar;23 Suppl 1:80-4. doi: 10.1159/000216913. Haemostasis. 1993. PMID: 8388356 Clinical Trial.

6

Managing the risk of thrombosis in the perioperative period in patients undergoing orthopedic and trauma surgery with low-molecular-weight heparin: enoxaparin.

Lassen MR, Borris LC. Lassen MR, et al. Among authors: borris lc. Orthopedics. 1997 Feb;20 Suppl:14-7. Orthopedics. 1997. PMID: 9048402

7

Low molecular weight heparin for the prevention of deep vein thrombosis following orthopedic surgery.

Lassen MR, Borris LC. Lassen MR, et al. Among authors: borris lc. Curr Opin Pulm Med. 1996 Jul;2(4):300-4. Curr Opin Pulm Med. 1996. PMID: 9363156 Review.

8

Deep-vein thrombosis prophylaxis in orthopedic surgery: hip surgery.

Lassen MR, Backs S, Borris LC, Kaltoft-Sørenson M, Coff-Ganes H, Jeppesen E. Lassen MR, et al. Among authors: borris lc. Semin Thromb Hemost. 1999;25 Suppl 3:79-82. Semin Thromb Hemost. 1999. PMID: 10549720 Review.

9

Dose relation in the prevention of proximal vein thrombosis with a low molecular weight heparin (tinzaparin) in elective hip arthroplasty.

Lassen MR, Borris LC, Jensen HP, Poulsen KA, Ejstrud P, Andersen BS. Lassen MR, et al. Among authors: borris lc. Clin Appl Thromb Hemost. 2000 Jan;6(1):53-7. doi: 10.1177/107602960000600109. Clin Appl Thromb Hemost. 2000. PMID: 10726050 Free article. Clinical Trial.

10

Prevention of thromboembolism in hip-fracture patients. Comparison of low-dose heparin and low-molecular-weight heparin combined with dihydroergotamine.

Lassen MR, Borris LC, Christiansen HM, Møller-Larsen F, Knudsen VE, Boris P, Nehen AM, Jurik AG, de Carvalho A, Nielsen BW, et al. Lassen MR, et al. Among authors: borris lc. Arch Orthop Trauma Surg. 1989;108(1):10-3. doi: 10.1007/BF00934150. Arch Orthop Trauma Surg. 1989. PMID: 2913977 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

124 results

Search Page